Results

Total Results: 2,212 records

Showing results for "drug".

61. Cover Page (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/it-architecture-for-post-marketing-surveillance-arizona-cert.pdf
    September 01, 2007 - for monitoring and detecting adverse drug events. … Detecting adverse drug events is a difficult problem. … interactions and monitoring drug safety. … (Center for Drug Evaluation and Research [CDER], 2005). … Reporting mechanisms need to be customized for each drug and drug combinations to collect relevant

62. Making Healthcare Safer IV: Protocols for High-Risk Drugs: Reducing Adverse Drug Events Related to Anticoagulants | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/high-risk-drugs/protocol
    September 01, 2023 - Reports Making Healthcare Safer IV: Protocols for High-Risk Drugs: Reducing Adverse Drug … Making Healthcare Safer IV: Protocols for High-Risk Drugs: Reducing Adverse Drug … Event Prevention (ADE Action Plan) identified anticoagulants as a leading cause of adverse drug events … cause-specific mortality, bleeding, hemorrhage, stroke, quality of life, adverse events associated with drug-drug … US Emergency Department Visits for Outpatient Adverse Drug Events, 2013-2014.

63. Comparative Effectiveness of Dietary Supplement Versus No Dietary Supplement Use in Adults Taking Cardiovascular Drugs | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/dietary-supplements/research-protocol
    December 01, 2019 - and Drug-Dietary Supplement Interactions: In the clinical setting, drug-supplement interactions are … more difficult to interpret than drug-drug interactions for a variety of reasons. … Due to U.S. drug regulatory policy, much more research and data are available describing drug-drug interactions … than drug-supplement interactions, and there is a clear need to synthesize information on drug-supplement … . . .cause alterations in cellular drug-transport mechanisms (e.g., drug-transport proteins)?

64. Integrating stakeholder preferences in comparative effectiveness research using multi-criteria decision analysis (MCDA) and Conjoint Analysis (CA) (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/mcda-ijzerman.pdf
    January 01, 2011 - pressure 3 US$ Drug C partial relief No adverse events 5 US$ Slide … use) of a drug to its impact of treatment (e.g., drug requires complex dosing schedule and monitoring … use) of a drug to its impact of treatment (e.g., drug requires complex dosing schedule and monitoring … This screen is titled: Goal: Select the best drug treatment. … Clinical Benefit (symptom relieve due drug use) Impact of Treatment (e.g. drug requires complex dosing

65. Misuse of Prescription Stimulants in Adults (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/misuse-prescription-protocol-amendment.pdf
    November 26, 2024 - Food and Drug Administration (FDA) has commissioned a rapid review on the misuse of attention-deficit … The National Institute on Drug Abuse (NIDA) describes misuse as: “taking a medication in a manner or … Drug Alcohol Depend. 2020 Apr 1;209:107907. doi: 10.1016/j.drugalcdep.2020.107907. … Misuse"[Mesh] OR "Drug Misuse"[Mesh] OR "Prescription Drug Diversion"[Mesh] OR "Substance Abuse, Oral … Misuse"[Mesh] OR "Drug Misuse"[Mesh] OR "Prescription Drug Diversion"[Mesh] OR "Substance Abuse, Oral

66. The Incident User Design in Comparative Effectiveness Research | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/incident-user-design/research
    August 01, 2019 - therapy and ignoring the duration of drug use. … For example, some propensity scores predict a combination of incident drug use, persistence with a drug … marketed drug. … Pharmacoepidemiol Drug Safety 2007;16:329-36. 4. Ray WA. … Pharmacoepidemiol Drug Safety 2006;15:81-92. 15. UKPDS Group.

67. App-F2-Surv-Report-2-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/app-f2-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - Harms of tricyclic antidepressants versus placebo Author, Year Quality Pain Population Drug Class Drug … Harms of pregabalin versus placebo Author, Year Quality Pain Population Drug Class Drug Assessment Time … Harms of pregabalin versus amitriptyline Author, Year Quality Pain Population Drug Class Drug Assessment … Harms of pregabalin CR versus IR Author, Year Quality Pain Population Drug Class Drug Assessment Time … Harms of cannabis versus placebo Author, Year Quality Pain Population Drug Assessment Time (Wk) Time

68. Drug Therapy for Early Rheumatoid Arthritis in Adults – An Update | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/rheumatoid-arthritis-medicine-update/research-protocol
    September 01, 2019 - Update SHARE: Drug … Page Contents Previous Report: Drug … However, data on disease-modifying antirheumatic drug (DMARD) use in the first 3 months are limited. … Choosing a RA treatment drug can be difficult with these populations. … Drug Therapy for Rheumatoid Arthritis in Adults: An Update [Internet].

69. Misuse of Prescription Stimulants in Adults | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/misuse-prescription
    February 01, 2025 - Food and Drug Administration (FDA) has commissioned a rapid review on the misuse of attention-deficit … The National Institute on Drug Abuse (NIDA) describes misuse as: “taking a medication in a manner or … Drug Alcohol Depend. 2020 Apr 1;209:107907. doi: 10.1016/j.drugalcdep.2020.107907. PMID: 32088588. … Misuse"[Mesh] OR "Drug Misuse"[Mesh] OR "Prescription Drug Diversion"[Mesh] OR "Substance Abuse, Oral … Misuse"[Mesh] OR "Drug Misuse"[Mesh] OR "Prescription Drug Diversion"[Mesh] OR "Substance Abuse, Oral

70. Evaluation of Effectiveness and Safety of Antiepileptic Medications in Patients with Epilepsy | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/epilepsy-medicine/research-protocol
    December 01, 2019 - drug, each newer antiepileptic drug will be compared individually against the older antiepileptic drug … innovator antiepileptic drug group, each generic antiepileptic drug will be compared individually against … the innovator antiepileptic drug (as a separate trial) by dividing the innovator antiepileptic drug … A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product … drug therapy.fs. randomly.ab. trial.ab. groups.ab.

71. Heroin | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/health-topics/heroin
    December 06, 2016 - It's an opioid drug made from morphine, a natural substance in the seedpod of the Asian poppy plant. … People who inject the drug also risk getting infectious diseases, including HIV/AIDS and hepatitis. … This means users need more and more drug to have the same effect. … NIH: National Institute on Drug Abuse Source https://medlineplus.gov/heroin.html Products

72. EHC Protocol: Addressing Social Isolation To Improve Health of Older Adults: A Rapid Evidence Review (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mhs4-computerized-cds-protocol.pdf
    May 08, 2023 - What is the frequency and severity of medication errors and adverse drug events? 2. … indicators have been used to examine the frequency and severity of medication errors and adverse drug … related to a drug”.1, 2 Adverse drug events are a leading type of healthcare-related harm, accounting … Medication Errors and Adverse Drug Events. … Adverse drug events in ambulatory care.

73. Dietary Supplements in Adults Taking Cardiovascular Drugs | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/dietary-supplements/research
    December 01, 2019 - This also poses risks of adverse events from supplement-drug interactions and nonadherence associated … by patients with cardiovascular disease, we examined benefits, harms, and effects on cardiovascular drug … reviewers included experimental and observational studies comparing a supplement plus cardiovascular drug … versus drug alone published in English or German; other languages were excluded due to concerns with … Conclusions Limitations of the evidence base precluded meaningful conclusions across most supplement-drug

74. Evaluating the Effects of Drug-Eluting and Bare Metal Stents in Patient Subgroups and Comparing Diagnostic Tools in Predicting Outcomes Following Stenting Procedures | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/coronary-stents-effects/abstract
    November 01, 2017 - Home Evidence Reports Evaluating the Effects of Drug-Eluting … SHARE: Evaluating the Effects of Drug-Eluting … Safety and efficacy of drug-eluting stents in older persons with chronic kidney disease: a report from … Project Timeline Evaluating the Effects of Drug-Eluting and Bare Metal Stents in Patient Subgroups … Internet Citation: Research Report: Evaluating the Effects of Drug-Eluting

75. Clopidogrel after Drug-Eluting Stent Implantation: Is current practice sufficient (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/stent-clopidogrel-practice_research.pdf
    March 01, 2009 - Clopidogrel after Drug-Eluting Stent Implantation: Is current practice sufficient The DEcIDE ( … Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. … Clopidogrel after drug-eluting stent implantation: is current practice sufficient? … Of the 4666 patients remaining, 3165 received a bare metal and 1501 a drug-eluting stent. … : an observational study of drug-eluting versus bare-metal stents.

76. Pharmacotherapy for Adults With Alcohol-Use Disorders in Outpatient Settings | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/alcohol-misuse-drug-therapy/research-protocol
    January 01, 2021 - Economic cost of alcohol and drug abuse in the United States, 1992: a report. … Hazardous drinkers and drug users in HMO primary care: prevalence, medical conditions, and costs. … Drug Alcohol Depend. 2006 Feb 1;81(2):149-55. PMID: 16043307. Hasin DS, Grant BF. … Drug and Alcohol Abuse: A Clinical Guide to Diagnosis and Treatment. 6th ed. … https://effectivehealthcare.ahrq.gov/products/alcohol-misuse-drug-therapy/research-protocol

77. Data Points #19: Medication Use in Medicare | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/medicare-medication-use/research
    December 01, 2019 - Multiple medications and use of psychotropic drugs increases the possibility of adverse drug events. … of Medicare beneficiaries who received at least one Medicare payment for an outpatient prescription drug … A major focus of Part D benefits is increased drug coverage for low-income individuals. … Advantage prescription drug plans (MA-PD plans) received low-income subsidy assistance. … and drug group use and catastrophic coverage use.

78. Dual Diagnosis | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/health-topics/dual-diagnosis
    September 13, 2012 - Description A person with dual diagnosis has both a mental disorder and an alcohol or drug … In particular, alcohol and drug problems tend to occur with Depression Anxiety disorders Schizophrenia … NIH: National Institute on Drug Abuse Source https://medlineplus.gov/dualdiagnosis.html

79. Female | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/health-topics/female
    February 19, 2025 - Healthcare Delivery and Outcomes Systematic Review Archived April 23, 2019 Long-Term Drug … Therapy and Drug Holidays for Osteoporosis Fracture Prevention: A Systematic Review Research … Protocol Archived April 12, 2018 Long-Term Drug Therapy and Drug Holidays for Osteoporotic

80. Medicines | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/health-topics/medicines
    December 06, 2016 - In the United States, the Food and Drug Administration is in charge of assuring the safety and effectiveness … Adults with Type 2 Diabetes Research Report August 26, 2008 Medicare Prescription Drug